Shilpa Lingala

1.5k citations
19 papers · 920 indexed · h-index 10
Topics
Liver Disease Diagnosis and Treatment (4 papers)Hepatitis B Virus Studies (4 papers)Hepatitis C virus research (4 papers)
Partner nations
United StatesChinaIndia

In The Last Decade

Shilpa Lingala

18 papers receiving 904 citations

Peers

Shilpa Lingala
Comparison fields: 5 of 82
  • Hepatology 306
  • Molecular Biology 264
  • Epidemiology 248
  • Physiology 199
  • Oncology 170
Replace Hirokazu Kawai with:
Hirokazu Kawai Japan
Mikiya Kitamoto Japan
Giridhar R. Gorla United States
Samuel J. Daniels Denmark
Kevin W. O’Connor United States
Gustavo dos Santos Fernandes Brazil
Helen Parfrey United Kingdom
Hye Won Lee South Korea
Qiang He China
Shilpa Lingala relative to Hirokazu Kawai Japan Hirokazu Kawai's profile →
Citations per field
00.5×3.4×
Hirokazu Kawai · 1×
Citations per year

Countries citing papers authored by Shilpa Lingala

Since Specialization
Citations

This map shows the geographic impact of Shilpa Lingala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilpa Lingala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilpa Lingala more than expected).

Fields of papers citing papers by Shilpa Lingala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilpa Lingala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilpa Lingala. The network helps show where Shilpa Lingala may publish in the future.

Co-authorship network of co-authors of Shilpa Lingala

This figure shows the co-authorship network connecting the top 25 collaborators of Shilpa Lingala. A scholar is included among the top collaborators of Shilpa Lingala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilpa Lingala. Shilpa Lingala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 42
5 9
6 37
7 1
8 266
9 11
10
Hepatitis B: Screening, Awareness, and the Need to Treat.
9
11 175
12 1
13 1
14 1
15 4
16 180
17 83
18 97
19 1

About Shilpa Lingala

Shilpa Lingala is a scholar working on Hepatology, Gastroenterology and Epidemiology, having authored 19 papers that have together received 920 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Hepatitis B Virus Studies (4 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Hepatology (306 citations), Aging (35 citations) and Physiology (199 citations). Shilpa Lingala has collaborated with scholars based in United States, China and India. Frequent co-authors include Marc G. Ghany, Jian Wu, Mark Α. Zern, Jan A. Nolta, Xiaoli Chen, Shiva Khoobyari, Theo Heller, Danielle M. Townsley, Neal S. Young and Delong Liu. Their work appears in journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026